Severe Asthma and Biologics: Managing Complex Patients.
Matucci A, Micheletto C, Vultaggio A.
J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):168-178. doi: 10.18176/jiaci.0856. Epub 2022 Sep 5.
Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson DJ, Akuthota P, Roufosse F.
Eur Respir Rev. 2022 Jan 25;31(163):210150. doi: 10.1183/16000617.0150-2021. Print 2022 Mar 31.
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
Pavord ID, Bel EH, Bourdin A, Chan R, Han JK, Keene ON, Liu MC, Martin N, Papi A, Roufosse F, Steinfeld J, Wechsler ME, Yancey SW.
Allergy. 2022 Mar;77(3):778-797. doi: 10.1111/all.15056. Epub 2021 Sep 16.
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y.
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2695-2709. doi: 10.1016/j.jaip.2022.05.019. Epub 2022 May 28.
Granulomatous vasculitis.
Marzano AV, Balice Y, Tavecchio S, Desimine C, Colombo A, Berti E.
G Ital Dermatol Venereol. 2015 Apr;150(2):193-202. Epub 2015 Mar 19.
Churg-Strauss syndrome.
Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M.
Autoimmun Rev. 2015 Apr;14(4):341-8. doi: 10.1016/j.autrev.2014.12.004. Epub 2014 Dec 11.
EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).
Hagemann J, Laudien M, Becker S, Cuevas M, Klimek F, Kianfar R, Casper I, Klimek L.
Allergol Select. 2024 Mar 21;8:18-25. doi: 10.5414/ALX02475E. eCollection 2024.
Adult-onset eosinophilic airway diseases.
Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M.
Allergy. 2020 Dec;75(12):3087-3099. doi: 10.1111/all.14620. Epub 2020 Oct 23.
Granuloma formation in ANCA-associated vasculitides.
Lamprecht P, Wieczorek S, Epplen JT, Ambrosch P, Kallenberg CG.
APMIS Suppl. 2009 Jun;(127):32-6. doi: 10.1111/j.1600-0463.2009.02474.x.
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
Del Pozo V, Bobolea I, Rial MJ, Espigol-Frigolé G, Solans Laqué R, Hernández-Rivas JM, Mora E, Crespo-Lessmann A, Izquierdo Alonso JL, Domínguez Sosa MS, Maza-Solano J, Atienza-Mateo B, Bañas-Conejero D, Moure AL, Rúa-Figueroa Í.
Front Immunol. 2024 Jan 5;14:1310211. doi: 10.3389/fimmu.2023.1310211. eCollection 2023.
